259 related articles for article (PubMed ID: 26035688)
21. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.
Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR
Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457
[TBL] [Abstract][Full Text] [Related]
22. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.
Li DW; Yao M; Dong YH; Tang MN; Chen W; Li GR; Sun BQ
Int J Mol Med; 2014 Nov; 34(5):1358-64. PubMed ID: 25174304
[TBL] [Abstract][Full Text] [Related]
23. Lactoferrin and anti-lactoferrin antibodies: effects of ironloading of lactoferrin on albumin extravasation in different tissues in rats.
Erga KS; Peen E; Tenstad O; Reed RK
Acta Physiol Scand; 2000 Sep; 170(1):11-9. PubMed ID: 10971218
[TBL] [Abstract][Full Text] [Related]
24. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
[TBL] [Abstract][Full Text] [Related]
25. Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment.
Fillebeen C; Ruchoux MM; Mitchell V; Vincent S; Benaïssa M; Pierce A
Brain Res Mol Brain Res; 2001 Nov; 96(1-2):103-13. PubMed ID: 11731015
[TBL] [Abstract][Full Text] [Related]
26. The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis.
Rousseau E; Michel PP; Hirsch EC
Mol Pharmacol; 2013 Dec; 84(6):888-98. PubMed ID: 24077968
[TBL] [Abstract][Full Text] [Related]
27. Endocytosis and degradation of bovine apo- and holo-lactoferrin by isolated rat hepatocytes are mediated by recycling calcium-dependent binding sites.
McAbee DD; Nowatzke W; Oehler C; Sitaram M; Sbaschnig E; Opferman JT; Carr J; Esbensen K
Biochemistry; 1993 Dec; 32(49):13749-60. PubMed ID: 8257710
[TBL] [Abstract][Full Text] [Related]
28. α-lipoic acid protects dopaminergic neurons against MPP+-induced apoptosis by attenuating reactive oxygen species formation.
Li DW; Li GR; Lu Y; Liu ZQ; Chang M; Yao M; Cheng W; Hu LS
Int J Mol Med; 2013 Jul; 32(1):108-14. PubMed ID: 23615851
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults.
Okawara M; Katsuki H; Kurimoto E; Shibata H; Kume T; Akaike A
Biochem Pharmacol; 2007 Feb; 73(4):550-60. PubMed ID: 17147953
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of apigenin against 1-methyl-4-phenylpyridinium ion‑induced neurotoxicity in PC12 cells.
Liu W; Kong S; Xie Q; Su J; Li W; Guo H; Li S; Feng X; Su Z; Xu Y; Lai X
Int J Mol Med; 2015 Mar; 35(3):739-46. PubMed ID: 25573459
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova ET; Sokolov AV; Pavlichenko NN; Kostevich VA; Abdurasulova IN; Chechushkov AV; Voynova IV; Elizarova AY; Kolmakov NN; Bass MG; Semak IV; Budevich AI; Kozhin PM; Zenkov NK; Klimenko VM; Kirik OV; Korzhevskii DE; Menshchikova EB; Vasilyev VB
Biometals; 2018 Jun; 31(3):425-443. PubMed ID: 29748743
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of Ndfip1 on MPP(+)-induced apoptosis in MES23.5 cells and its underlying mechanisms.
Liu K; Xu H; Xiang H; Sun P; Xie J
Exp Neurol; 2015 Nov; 273():215-24. PubMed ID: 26300475
[TBL] [Abstract][Full Text] [Related]
33. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
34. Superoxide dismutase-like activity of metal substituted lactoferrin derivatives.
Ishisaka R; Kanno T; Kanematsu H; Utsumi T; Akiyama J; Horton AA; Yoshioka T
Physiol Chem Phys Med NMR; 1998; 30(1):1-13. PubMed ID: 9807232
[TBL] [Abstract][Full Text] [Related]
35. Binding and endocytosis of apo- and holo-lactoferrin by isolated rat hepatocytes.
McAbee DD; Esbensen K
J Biol Chem; 1991 Dec; 266(35):23624-31. PubMed ID: 1660879
[TBL] [Abstract][Full Text] [Related]
36. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage.
Liu B; Qin L; Yang SN; Wilson BC; Liu Y; Hong JS
J Pharmacol Exp Ther; 2001 Sep; 298(3):1133-41. PubMed ID: 11504811
[TBL] [Abstract][Full Text] [Related]
37. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
Faucheux BA; Nillesse N; Damier P; Spik G; Mouatt-Prigent A; Pierce A; Leveugle B; Kubis N; Hauw JJ; Agid Y
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9603-7. PubMed ID: 7568181
[TBL] [Abstract][Full Text] [Related]
38. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
39. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.
Kim HG; Ju MS; Shim JS; Kim MC; Lee SH; Huh Y; Kim SY; Oh MS
Br J Nutr; 2010 Jul; 104(1):8-16. PubMed ID: 20187987
[TBL] [Abstract][Full Text] [Related]
40. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
